1. Home
  2. Live Updates
  3. Biotech networks virtual speed networking

Page 29 - Biotech Networks Virtual Speed Networking News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotech networks virtual speed networking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotech Networks Virtual Speed Networking Today - Breaking & Trending Today

Competition winner aims to transform cell culture space

Bringing a fresh approach to the cell culture market, Alt Biotech, (Paris, France) has been chosen as a winner of the 'INTEGRA supports start-ups’ competition, receiving 12 EVOLVE manual pipettes and $1000 worth of GRIPTIPS® pipette tips to help develop its potentially game-changing technologies. Click to read more. ....

France General , Alt Biotech , Jade Pellet ,

Proteomics International Laboratories Ltd (ASX:PIQ) Investor Presentation

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to Jefferies Institutional Clients on 28 March 2024. ....

Western Australia , Proteomics International Laboratories , Proteomics International , Proteomics International Laboratories Ltd , International Laboratories Ltd , Jefferies Institutional Clients , International Laboratories , Health Pharm Generalproteomics International Laboratories Ltd , Asx Piq ,

Surrozen Announces Safety, Pharmacodynamic and Liver

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043. ....

Craig Parker , Surrozen Inc , Boehringer Ingelheim , Office Of Surrozen , Company Nasdaq , Initiating Phase , Present Safety , Upcoming Medical Meeting , Wnt Pathway , Chief Executive Office , Severe Alcohol Associated , Nasdaq Srzn , Alcohol Associated Hepatitis , Nt Modulation , Ont Pathway , Hase 1a Results ,

Vertex moves kidney disease drug into late-stage testing

BioPharma ....

Drug Administration , Vertex Pharmaceuticals On , Dive Brief , New England Journal , Clinical Trials ,

Ocugen to Host Conference Call on Tuesday, April 2 at 8:30

MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,. ....

Exchange Commission , Head Of Communications , Ocugen Inc , Private Securities Litigation Reform Act , Nasdaq Ocgn , Gene Therapy ,